Date: 2016-08-24
Type of information: Resignation
Compound:
Company: Neurovive Pharmaceutical (Sweden)
Therapeutic area:
Type agreement: resignation
Action mechanism:
Disease:
Details: * On August 24, 2016, NeuroVive Pharmaceutical announcef that its Chief Operating Officer, Jan Nilsson leaves the company. The company is entering into a very important period and is expecting exciting developments during the fall. Over the past several months, the business strategy and organization have been re-oriented to optimize the way forward. As one consequence the position of COO is no longer required.
Financial terms:
Latest news:
